4 registrations that name moringa as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.
Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.
Filter 4 registrations
Status
Phase
1US sites across 1 state
1
2 to 4
5 to 19
20 or more
All 4 registrations
Not yet recruitingNCT07605091
RELIANCE: Moringa in Lactation and Early Childhood
No phase
Philip Kern
About 100 people
Starts Nov 2026 (estimated)
In plain words A study of moringa in female participants 7 days to 99, run by Philip Kern. It plans to enroll about 100 people at 1 US site.
Who it lists and where
Who the trial lists, as registered
Lists female participants 7 days to 99; healthy volunteers accepted. Conditions: Breast Feeding; Lactation.
Mothers: Inclusion criteria - >18 years of age, s/p delivery of a healthy infant, and planning breast feeding.
Infants: must be born at term (=37-42 weeks), singleton birth, lactating, age 7-21 days at enrollment
The exclusion criteria are on the listing.
What it tests, as registered
Moringa Leaf Powder; Carrier
Registered summary
This study will assess the impact of maternal moringa supplementation to mothers of breastfeeding infants on milk output, milk composition, exclusive breastfeeding duration, and maternal and child health. This will be accomplish by conducting a randomized, controlled dietary intervention study enrolling breastfeeding mothers and their newborn infants. Mothers will be randomized to receive either 10g dried moringa leaf powder in carrier vs. carrier alone, consumed daily for four months, with follow-up for 2 years. The full summary is on the listing.
Where, as registered
1 US site in 1 state.
Not yet recruitingNCT04575948
Anticariogenic Effect of Moringa Oleifera Mouthwash Compared to Chlorhexidine Mouthwash
Phase 2 and 3
Misr International University
About 90 people
Starts Dec 2027 (estimated)
In plain words A Phase 2 and 3 study of moringa in people 18 to 50, run by Misr International University. It plans to enroll about 90 people and lists no sites yet.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 50. Conditions: Plaque, Dental; Antimicrobial; Mouthwash; Cytotoxicity.
Systemically free as reported by the patients
Minimum of 20 teeth present in the dentition (excluding wisdom teeth);
Clinically healthy gingiva (on intact periodontium)
Dental biofilm-induced gingivitis (plaque induced gingivitis) according to the criteria set by the American Academy of Periodontology for classification of periodontal diseases and conditions in 2017
1 more inclusion criterion and the exclusion criteria are on the listing.
What it tests, as registered
Moringa Oleifera; Chlorhexidine mouthwash; Base formula
Registered summary
Moringa oleifera (MO) is an extraordinary nutritious vegetable tree with high medicinal value for its antibacterial properties. Formulation of various natural dental remedies from this plant and their testing for their effectiveness might yield promising antibacterial, antiplaque and anticariogenic agents with minimal side effects. Aim of the study: Part I: The aim of this in-vitro part of the study is to formulate a nontoxic mouthwash from MO leaves extract, having antimicrobial activity, to be used in part II of the study. The full summary is on the listing.
Where, as registered
No sites listed yet.
Not yet recruitingNCT06948526
Evaluation of Moringa Oleifera Leaf Extract Versus Sodium Hypochlorite in Pulpectomy of Nonvital Primary Molars
No phase
Cairo University
About 50 people
Starts Jun 1, 2025 (estimated)
In plain words A study of moringa in people 3 to 7, run by Cairo University. It plans to enroll about 50 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 3 to 7. Conditions: Nonvital Primary Molars.
Cooperative children aged between 3-7 years
Males/Females.
Primary molars necessitating pulpectomy diagnosed with deep dental caries with pulp necrosis and periapical pathosis or both.
This randomized clinical trial aims to compare the clinical and radiographic success of Moringa Oleifera leaf extract with Sodium Hypochlorite as intracanal irrigants in pulpectomy of nonvital primary molars in children aged 3-7 years. The study evaluates both clinical parameters (pain, swelling, mobility) and radiographic healing (periapical changes, root resorption) over 12 months.
Where, as registered
No US site; Egypt (1).
Not yet recruitingNCT06905379
Remineralization Efficacy of Moringa Oleifera Varnish Vs MI Varnish in Initial Carious Lesions Over 6 Months Follow Up: a Randomized Controlled Clinical Trial
No phase
Cairo University
About 40 people
Starts May 1, 2025 (estimated)
In plain words A study of moringa in people 25 to 35, run by Cairo University. It plans to enroll about 40 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 25 to 35; healthy volunteers accepted. Conditions: White Spot Lesions [Initial Caries] on Smooth Surface of Tooth; Moringa Oleifera.
Presentation with at least one active WSLs on the study teeth at the start of the study.
Good oral hygiene.
Co-operative patients approving to participate in the trial.
Have sufficient cognitive ability to understand consent procedures Inclusion criteria of teeth.
5 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Moringa Oleifera; Varnish
Registered summary
This randomized clinical trial aimed to test the remineralization effect of laboratory prepared Moringa Oleifera based varnish compared to MI varnish (CPP-ACP) on incipient carious lesions. The study could include any of the following participants: age: 25-35 years, males or females, presentation with at least one active WSLs on the study teeth at the start of the study, good oral hygiene, co-operative patients approving to participate in the trial, have sufficient cognitive ability to understand consent procedures. The full summary is on the listing.